Development of synovial sarcoma organoids exhibiting ferroptosis resistance despite low malic enzyme 1 expressionToru Wakamatsu(Osaka International Cancer Institute), Satoshi Takenaka(Osaka International Cancer Institute)Research SquareJune 25, 202510.21203/rs.3.rs-6871133/v1Cited by 0SaveCiteExport RISWatch citationsRelated PapersPrognostic implication of SYT-SSX fusion type in synovial sarcoma: A multi-institutional retrospective analysis in Japan|Oncology Reports|2008|60Development of synovial sarcoma organoids exhibiting ferroptosis resistance despite low malic enzyme 1 expression|Scientific Reports|2025|0